4don MSN
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...
German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market ...
Novo Nordisk’s experimental drug CagriSema helped people who are overweight or obese and have diabetes lose about 14% of their body weight over 68 weeks, or 11 percentage points more than those given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback